References and Notes
1a
Craig NC.
Chen A.
Suh KH.
Klee S.
Mellau GC.
Winnewisser BP.
Winnewisser M.
J. Am. Chem. Soc.
1997,
119:
4789
1b
Briggs CRS.
Allen MJ.
O’Hagan D.
Tozer DJ.
Slawin AMZ.
Goeta AE.
Howard JAK.
Org. Biomol. Chem.
2004,
2:
732
1c
Schuler M.
O’Hagan D.
Slawin AMZ.
Chem. Commun.
2005,
4324
2
Shimizu M.
Hiyama T.
Angew. Chem. Int. Ed.
2005,
44:
214 ; and references therein
3a
Kirsch P.
Bremer M.
Angew. Chem. Int. Ed.
2000,
39:
4217
3b
Vlahakis JZ.
Wand MD.
Lemieux RP.
J. Am. Chem. Soc.
2003,
125:
6862
4a
Rzepa HS.
O’Hagan D.
Chem. Commun.
1997,
645
4b
Yoder NC.
Kumar K.
Chem. Soc. Rev.
2002,
31:
335
4c
Hodges JA.
Raines RT.
J. Am. Chem. Soc.
2003,
125:
9262
5a
Fried J.
Sabo EF.
J. Am. Chem. Soc.
1954,
76:
1455
5b
Bouzard D.
Dicesare P.
Essiz M.
Jacquet JP.
Kiechel JR.
Remuzon P.
Weber A.
Oki T.
Masuyoshi M.
Kessler RE.
Fung-Tomc J.
Desiderio J.
J. Med. Chem.
1990,
33:
1344
5c
Xu Y.
Qian L.
Prestwich GD.
J. Org. Chem.
2003,
68:
5320
5d
Haffner CD.
McDougald DL.
Reister SM.
Thompson BD.
Conlee C.
Fang J.
Bass J.
Lenhard JM.
Croom D.
Secosky-Chang MB.
Tomaszek T.
McConn D.
Wells-Knecht K.
Johnson PR.
Bioorg. Med. Chem. Lett.
2005,
15:
5257
6a
Lal GS.
Pez GP.
Pesaresi RJ.
Prozonic FM.
Chem. Commun.
1999,
215
6b
Lal GS.
Pez GP.
Pesaresi RJ.
Prozonic FM.
Cheng HJ.
J. Org. Chem.
1999,
64:
7048
7a
Middleton WJ.
J. Org. Chem.
1975,
40:
574
7b
Hudlicky M.
Org. React.
1988,
35:
513
8 For a review, see: Singh RP.
Shreeve JM.
Synthesis
2002,
2561
For examples, see:
9a
Rozen S.
Faust Y.
Ben-Yakov H.
Tetrahedron Lett.
1979,
20:
1823
9b
Shiuey SJ.
Kulesha I.
Baggiolini EG.
Uskokovic MR.
J. Org. Chem.
1990,
55:
243
9c
Jeong LS.
Moon HR.
Yoo SJ.
Lee SN.
Chun MW.
Lim Y.-H.
Tetrahedron Lett.
1998,
39:
5201
9d
Boukerb A.
Grée D.
Laabassi M.
Grée R.
J. Fluorine Chem.
1998,
88:
23
9e
Phillips AJ.
Uto Y.
Wipf P.
Reno MJ.
Williams DR.
Org. Lett.
2000,
2:
1165
9f
Hallett DJ.
Gerhard U.
Goodacre SC.
Hitzel L.
Sparey TJ.
Thomas S.
Rowley M.
J. Org. Chem.
2000,
65:
4984
9g
Grunewald GL.
Cadwell TM.
Li Q.
Criscione KR.
J. Med. Chem.
2001,
44:
2849
9h
Lakshmipathi P.
Grée D.
Grée R.
Org. Lett.
2002,
4:
451
9i
Vera-Ayoso Y.
Borrachero P.
Cabrera-Escribano F.
Carmona AT.
Gomez-Guillen M.
Tetrahedron: Asymmetry
2004,
15:
429
10a
Somekh L.
Shanzer A.
J. Am. Chem. Soc.
1982,
104:
5836
10b
Gani D.
Hitchcock PB.
Young DW.
J. Chem. Soc., Perkin Trans. 1
1985,
1363
10c
Furneaux RH.
Gainsford GJ.
Mason JM.
Tyler PC.
Tetrahedron
1994,
50:
2131
10d
Furneaux RH.
Mason JM.
Tyler PC.
Tetrahedron Lett.
1994,
35:
3143
10e
Floreancig PE.
Swalley SE.
Trauger JW.
Dervan PB.
J. Am. Chem. Soc.
2000,
122:
6342
10f
Hook DF.
Gessier F.
Noti C.
Kast P.
Seebach D.
ChemBioChem
2004,
5:
691
10g
Ye C.
Shreeve JM.
J. Fluorine Chem.
2004,
125:
1869
For comprehensive reviews, see:
11a
Cossy J.
Gomez Pardo D.
Chemtracts: Org. Chem.
2002,
15:
579
11b
Cossy J.
Gomez Pardo D.
Targets in Heterocyclic Systems - Chemistry and Properties
Vol. 6:
Attanasi OA.
Spinelli D.
Italian Society of Chemistry;
Rome, Italy:
2002.
p.1
12a
Cossy J.
Dumas C.
Michel P.
Gomez Pardo D.
Tetrahedron Lett.
1995,
36:
549
12b
Cossy J.
Dumas C.
Gomez Pardo D.
Synlett
1997,
905
12c
Cossy J.
Dumas C.
Gomez Pardo D.
Bioorg. Med. Chem. Lett.
1997,
7:
1343
12d
Cossy J.
Dumas C.
Gomez Pardo D.
Eur. J. Org. Chem.
1999,
1693
12e
Cossy J.
Mirguet O.
Gomez Pardo D.
Synlett
2001,
1575
12f
Brandi A.
Cicchi S.
Paschetta V.
Gomez Pardo D.
Cossy J.
Tetrahedron Lett.
2002,
43:
9357
12g
Déchamps I.
Gomez Pardo D.
Karoyan P.
Cossy J.
Synlett
2005,
1170
12h
Déchamps I.
Gomez Pardo D.
Cossy J.
ARKIVOC
2007,
(v):
38
13
General Procedure for the Ring Expansion of Prolinols 1-5 and 19-23.
To a stirred solution of prolinol (0.5 mmol) in THF or CH2Cl2 (5 mL) at 0 °C, DAST (0.7 mmol) was added dropwise. After 1 h, the cooling bath was removed and the reaction mixture was stirred at r.t. for 1 h. The reaction was worked up by cooling to 0 °C followed by careful addition of a sat. NaHCO3 solution (10 mL). The mixture was extracted twice with EtOAc (30 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane-Et2O (9:1) as eluant.
14
Meng-Yang C.
Chung-Yi C.
Min-Ruey T.
Tze-Wie T.
Nein-Chen C.
Synthesis
2004,
840
15
Heindl C.
Hübner H.
Gmeiner P.
Tetrahedron: Asymmetry
2003,
14:
3153
16 Compound 12: [α]D
20 -6.7 (c 0.135, CHCl3). IR (neat): 2921, 1460, 1252, 1153, 1090, 835, 776, 739, 699 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.40-7.15 (m, 5 H), 4.80 (dm, J = 47.2 Hz, 1 H), 4.06 (dddd, J = 9.5, 9.5, 4.5, 4.5 Hz, 1 H), 3.64 (d, J = 13.4 Hz, 1 H), 3.52 (d, J = 13.4 Hz, 1 H), 2.92-2.79 (m, 2 H), 2.29-1.99 (m, 3 H), 1.59-1.36 (m, 1 H), 0.83 (s, 9 H), 0,03 (s, 3 H), 0,01 (s, 3 H). 13C NMR: δ = 137.5 (s), 129.0 (d), 128.3 (d), 127.1 (d), 87.9 (dd,
¹
J
C-F = 171.2 Hz), 65.1 (d), 62.3 (t), 60.2 (t), 56.0 (dt, 2
J
C-F = 20.2 Hz), 38.8 (dt, 2
J
C-F = 20.2 Hz), 25.8 (q), 18.1 (s), -4.8 (q). MS (EI): m/z (relative intensity) = 323 (2) [M+], 308 (3), 303 (2), 290 (2), 266 (31), 246 (4), 232 (2), 192 (3), 191 (4), 190 (3), 134 (11), 102 (2), 100 (2), 92 (9), 91 (100), 77 (3), 75 (4), 73 (10), 65 (3), 59 (3). HRMS: m/z calcd for C18H31NFOSi [MH]+: 324.2159; found: 324.2151.
17 Compound 14: [α]D
20 +37.6 (c 0.35, CHCl3). IR (neat): 3069, 2930, 2856, 2800, 1588, 1471, 1427, 1360, 1154, 1105, 1027, 976, 821, 738, 698 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.65-7.58 (4 H), 7.43-7.21 (11 H), 4.83 (ddddd, J = 47.7, 5.0, 5.0, 2.5, 2.5 Hz, 1 H), 4.13 (dddd, J = 8.0, 8.0, 4.0, 4.0 Hz, 1 H), 3.50 (s, 2 H), 2.74-2.58 (m, 2 H), 2.40 (ddd, J = 29.1, 12.1, 2.0 Hz, 1 H), 2.15 (m, 1 H), 1.98 (m, 1 H), 1.67 (m, 1 H), 1.04 (s, 9 H). 13C NMR (100 MHz, CDCl3): δ = 137.6 (s), 135.7 (d), 134.2 (s), 134.0 (s), 129.7 (d), 129.6 (d), 129.0 (d), 128.2 (d), 127.7 (d), 127.6 (d), 127.1 (d), 87.7 (dd, J = 170 Hz), 66.2 (dd, J = 3 Hz), 62.2 (t), 59.6 (t), 56.3 (dt, J = 21 Hz), 38.5 (dt, J = 20 Hz), 27.0 (q), 19.2 (s). MS (EI): m/z (relative intensity) = 447 (1) [M+], 414 (2), 392 (7), 391 (27), 390 (82), 370 (4), 225 (3), 222 (3), 201 (8), 199 (10), 192 (7), 191 (6), 183 (9), 181 (6), 170 (5), 135 (7), 92 (8), 91 (100), 65 (3). HRMS: m/z calcd for C28H35NFOSi [MH]+: 448.2472; found: 448.2473.
18
Seebach D.
Boes M.
Naef R.
Schweizer WB.
J. Am. Chem. Soc.
1983,
105:
5390
19 Compound 28: [α]D
20 +6.6 (c 0.35, CHCl3). IR (neat): 2930, 2856, 2786, 1460, 1427, 1384, 1252, 1180, 1106, 1083, 1048, 936, 888, 821, 776, 739, 700 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.67-7.63 (m, 4 H), 7.42-7.33 (m, 6 H), 4.12 (dddd, J = 10.1, 10.1, 5.0, 5.1 Hz, 1 H), 2.90-2.83 (m, 1 H), 2.79-2.73 (m, 1 H), 2.22 (s, 3 H), 2.11-2.03 (m, 1 H), 2.00-1.78 (m, 2 H), 1.63-1.51 (m, 3 H), 1.06 (s, 9 H), 0.89 (t, J = 7.5 Hz, 3 H). 13C NMR: δ = 135.7 (d), 134.1 (s), 129.7 (d), 127.6 (d), 95.1 (ds, 1
J
C-F = 172 Hz), 66.4 (d), 62.3 (t), 61.7 (dt, 2
J
C-F = 21.2 Hz), 45.8 (q), 41.4 (dt, 2
J
C-F = 22.0 Hz), 31.4 (dt, 2
J
C-F = 22.7 Hz), 27.0 (q), 19.2 (s), 7.10 (q). MS (EI): m/z (relative intensity) = 399 (2) [M+], 379 (12), 364 (9), 343 (28), 342 (100), 322 (15), 225 (7), 201 (11), 199 (13), 183 (18), 181 (10), 144 (18), 124 (30), 122 (23), 94 (11), 58 (12).
20 The ee values were determined by HPLC: OJ-H, hexane, 0.3 mL/min.
21
Métro T.-X.
Appenzeller J.
Gomez Pardo D.
Cossy J.
Org. Lett.
2006,
8:
3509
Benzyl and allyl neighboring groups are reported to participate in DAST reactions in the absence of internal nucleophile, for examples, see:
22a
Haigh D.
Jefcott LJ.
Magge K.
McNab H.
J. Chem. Soc., Perkin Trans. 1
1996,
1895
22b
Burnell-Curty C.
Faghih R.
Pagano T.
Henry RF.
Lartey PA.
J. Org. Chem.
1996,
61:
5153